Ozempic, also known as semaglutide, is a medication used to treat type 2 diabetes. It works in the body by mimicking the action of a natural hormone called glucagon-like peptide-1 (GLP-1). GLP-1 is produced in the intestines and helps regulate blood sugar levels by promoting the release of insulin from the pancreas.

When you eat, your body breaks down the carbohydrates into glucose, which is then absorbed into the bloodstream. Normally, the pancreas responds by releasing insulin to help cells absorb glucose and lower blood sugar levels. However, in people with type 2 diabetes, the pancreas's ability to produce insulin is impaired.

Ozempic works by enhancing the body's natural response to glucagon and glucose. When taken orally, it is absorbed into the bloodstream and travels to the pancreas, where it binds to GLP-1 receptors. This binding action triggers a series of physiological responses that help regulate blood sugar levels [1].

One of the primary actions of Ozempic is to slow gastric emptying, which helps reduce the speed at which glucose enters the bloodstream after a meal. This slow-down effect is particularly beneficial for people with type 2 diabetes, as it helps maintain more consistent blood sugar levels throughout the day [2].

In addition to slowing gastric emptying, Ozempic also stimulates the release of insulin from the pancreas. This insulin release helps cells absorb glucose from the bloodstream, further reducing blood sugar levels. At the same time, Ozempic also reduces the production of glucagon, a hormone that raises blood sugar levels by stimulating the liver to release stored glucose into the bloodstream [3].

The combination of these actions results in improved glucose control, weight loss, and reduced blood sugar levels in people with type 2 diabetes. According to a study published in the New England Journal of Medicine, Ozempic significantly reduced HbA1c levels, weight, and systolic blood pressure in patients with type 2 diabetes compared to placebo [4].

For more information on Ozempic and its mechanism of action, visit the DrugPatentWatch website DrugPatentWatch.com .

Sources:
[1] http://www.drugbank.ca/drugs/DB09083
[2] https://pubchem.ncbi.nlm.nih.gov/compound/Semaglutide
[3] https://www.ncbi.nlm.nih.gov/pubmed/29244155
[4] https://www.nejm.org/doi/full/10.1056/NEJMoa1714648